Clin2
NCT07685964Possibly a fitNot yet recruiting

Pregnenolone for cannabis use and depression

Cannabis Use DisorderMajor Depressive Disorder (MDD)

Treatments studied

Part of Mental health clinical trials.

This study tests if a natural hormone called pregnenolone can help people who use cannabis frequently and also have depression. You would take pregnenolone pills and see if your cannabis use and mood improve.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
20 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old
  • You have been diagnosed with cannabis use disorder and major depression
  • You use cannabis at least 4 days a week
  • You have a positive urine test for THC
  • You are willing to try to cut back on cannabis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07734701Not yet recruiting· Phase 2
Pregnenolone for alcohol use and depression

This trial tests if a natural steroid called pregnenolone can help people who have both alcohol use disorder and major depression. You would take the study medication for several weeks and have brain scans and mood assessments to see if it reduces drinking and improves mood.

Dallas, Texas
NCT06878859Recruiting
Online program for depression and cannabis use

This study tests a digital (online) program designed to help people who struggle with both depression and cannabis use. If you're feeling down and also using cannabis more than you'd like, this program might help you manage both.

Boston, Massachusetts
NCT06660381Recruiting· Phase 1
Psilocybin therapy for cannabis use disorder

This study tests if psilocybin (a substance that can change how you think and feel) can help people reduce or stop using cannabis. You will receive support and be monitored closely throughout the trial.

Baltimore, Maryland
NCT05885542Recruiting· Phase 1/Phase 2
Testing CBD pills for cannabis use and stress in young adults

This early-phase study tests whether a CBD pill (compared with a placebo sugar pill) can affect cannabis use and stress in people ages 18–25 who use cannabis very frequently. It may help your stress levels and cannabis-related symptoms while researchers carefully monitor safety and abstinence periods during visits.

Charleston, South Carolina
NCT07265752Not yet recruiting· Phase 2
Tirzepatide for severe cannabis use disorder

This trial tests if tirzepatide, a hormone-like medicine, can help people with severe cannabis use disorder reduce their cannabis use. It may work by changing how your body responds to certain signals.

NCT05859347Recruiting
Brain stimulation study for cannabis use disorder

This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.

Toronto, Ontario

Hear when a new Cannabis Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.